The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Molecular Pathogenesis of Osteosarcoma
Abstract
Osteosarcoma is a devastating but rare disease, whose study has illuminated both the basic biology and clinical management of cancer over the past 30 years. These contributions have included insight into the roles of key cancer genes such as the retinoblastoma tumor suppressor gene and TP53, the identification of familial cancer syndromes implicating DNA helicases, and dramatic improvements in survival by the use of adjuvant chemotherapy. This review provides a synoptic overview of our current understanding of the molecular causes of osteosarcoma, and suggests future directions for study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“The RecQ helicases are involved in maintaining genomic stability by functioning at the interface between DNA replication and recombination to repair damaged replication forks (Lengauer et al ., 1998; Chakraverty and Hickson, 1999; Bachrati and Hickson, 2003).”
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,078
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Positional Cloning of the Werner's Syndrome Gene
Yu, C.-E., Oshima, J., Fu, Y.-H., Wijsman, E. M., Hisama, F., Alisch, R., Matthews, S., Nakura, J., Miki, T., Ouais, S., et al. (1996) · Science · doi:10.1126/science.272.5259.258 · Cited by 1,722
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R. (1997) · Nature Medicine · doi:10.1038/nm1197-1271 · Cited by 1,292
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221 · cited 1×
“…other caretaker proteins including BASC (BRCA associated genomic surveillance complex) a multien-zyme complex that contains genes involved in DNA metabolism and repair including BRCA1, mismatch repair gene 1, MRE11, Nijmegen breakage syndrome protein and ataxia telangiectasia (Wang et al ., 2000).”
The Bloom's syndrome helicase suppresses crossing over during homologous recombination
Wu, L., & Hickson, I. D. (2003) · Nature · doi:10.1038/nature02253 · Cited by 1,085
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., Waard, R. D., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Rajagopalan, H., & Lengauer, C. (2004) · Nature · doi:10.1038/nature03099 · Cited by 725
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M., & Helman, L. J. (2004) · Nature Medicine · doi:10.1038/nm982 · Cited by 705
RecQ helicases: caretakers of the genome
Hickson, I. D. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1012 · Cited by 680
A Twist Code Determines the Onset of Osteoblast Differentiation
Bialek, P., Kern, B., Yang, X., Schrock, M., Sosic, D., Hong, N., Wu, H., Yu, K., Ornitz, D. M., Olson, E. N., et al. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00058-9 · Cited by 674
Pleiotropic effects of a null mutation in the c-fos proto-oncogene
Johnson, R. S., Spiegelman, B. M., & Papaioannou, V. (1992) · Cell · doi:10.1016/0092-8674(92)90592-z · Cited by 637
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610
The Werner syndrome protein is a DNA helicase
Gray, M. D., Shen, J.-C., Kamath-Loeb, A. S., Blank, A., Sopher, B. L., Martin, G. M., Oshima, J., & Loeb, L. A. (1997) · Nature Genetics · doi:10.1038/ng0997-100 · Cited by 603
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.278.15.1262 · Cited by 570
Boland, G. M., Perkins, G., Hall, D. J., & Tuan, R. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20284 · Cited by 569
The p53/p63/p73 family of transcription factors: overlapping and distinct functions
Levrero, M., Laurenzi, V. D., Costanzo, A., Sabatini, S., Gong, J., Wang, J. Y. J., & Melino, G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1661 · Cited by 565
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 1×
“SQSTM1 mediates signaling via IL-1/TNF pathway to NF-kB, and MAPK9, and is part of the RANK-signaling pathway (Laurin et al ., 2002).”
Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus
Motoyama, J., Liu, J., Mo, R., Ding, Q., Post, M., & Hui, C.-C. (1998) · Nature Genetics · doi:10.1038/1711 · Cited by 560
The Bloom's syndrome gene product promotes branch migration of Holliday junctions
Karow, J. K., Constantinou, A., Li, J.-L., West, S. C., & Hickson, I. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100448097 · Cited by 502
Dorfman, H. D., & Czerniak, B. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v · Cited by 496
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Vahteristo, P., Bartkova, J., Eerola, H., Syrjäkoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomäki, K., Heikkilä, P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341943 · Cited by 467
High-frequency developmental abnormalities in p53-deficient mice
Armstrong, J. F., Kaufman, M. H., Harrison, D. J., & Clarke, A. R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00183-7 · Cited by 467
Excess of rare cancers in Werner syndrome (adult progeria).
Goto, M., Miller, R. W., Ishikawa, Y., & Sugano, H. (1996) · PubMed · Cited by 431
The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment
He, X., He, X., Dave, V. P., Zhang, Y., Hua, X., Nicolas, E., Xu, W., Roe, B. A., & Kappes, D. J. (2005) · Nature · doi:10.1038/nature03338 · Cited by 418
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition.
Hansen, M. F., Koufos, A., Gallie, B. L., Phillips, R. A., Fodstad, O., Brøgger, A., Gedde-Dahl, T., & Cavenee, W. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6216 · Cited by 415
Franklin, D. S., Godfrey, V. L., Lee, H., Kovalev, G. I., Schoonhoven, R., Chen-Kiang, S., Su, L., & Xiong, Y. (1998) · Genes & Development · doi:10.1101/gad.12.18.2899 · Cited by 412
McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T., & Jacks, T. (1998) · Genes & Development · doi:10.1101/gad.12.8.1121 · Cited by 388
Constantinou, A., Tarsounas, M., Karow, J. K., Brosh, R. M., Bohr, V. A., Hickson, I. D., & West, S. C. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd004 · Cited by 387
Cancer predisposition caused by elevated mitotic recombination in Bloom mice
Luo, G., Santoro, I. M., McDaniel, L. D., Nishijima, I., Mills, M., Youssoufian, H., Vogel, H., Schultz, R. A., & Bradley, A. (2000) · Nature Genetics · doi:10.1038/82548 · Cited by 372
RecQ helicases: suppressors of tumorigenesis and premature aging
BACHRATI, C. Z., & HICKSON, I. D. (2003) · Biochemical Journal · doi:10.1042/bj20030491 · Cited by 371
Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00327-6 · Cited by 361
Self-citationOsteoblasts are target cells for transformation in c-fos transgenic mice
Grigoriadis, A., Schellander, K., Wang, Z., & Wagner, E. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.685 · Cited by 350
Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene
Nishio, Y., Dong, Y., Paris, M., O'Keefe, R. J., Schwarz, E. M., & Drissi, H. (2006) · Gene · doi:10.1016/j.gene.2005.12.022 · Cited by 346
MDM2 gene amplification in metastatic osteosarcoma.
Ladanyi, M., Cha, C. H., Lewis, R., Jhanwar, S. C., Huvos, A. G., & Healey, J. H. (1993) · PubMed · Cited by 340
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Deregulated c-fos expression interferes with normal bone development in transgenic mice
Rüther, U., Garber, C., Komitowski, D., Müller, R., & Wagner, E. F. (1987) · Nature · doi:10.1038/325412a0 · Cited by 332
Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
Graña, X., Garriga, J., & Mayol, X. (1998) · Oncogene · doi:10.1038/sj.onc.1202575 · Cited by 326
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions
Lallemand, D., Curto, M., Saotome, I., Giovannini, M., & McClatchey, A. I. (2003) · Genes & Development · doi:10.1101/gad.1054603 · Cited by 324
p107 is a suppressor of retinoblastoma development in pRb-deficient mice
Robanus-Maandag, E., Dekker, M., van der Valk, M., Carrozza, M.-L., Jeanny, J.-C., Dannenberg, J.-H., Berns, A., & te Riele, H. (1998) · Genes & Development · doi:10.1101/gad.12.11.1599 · Cited by 320
The Bloom's Syndrome Gene Product Interacts with Topoisomerase III
Wu, L., Davies, S. L., North, P. S., Goulaouic, H., Riou, J.-F., Turley, H., Gatter, K. C., & Hickson, I. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9636 · Cited by 318
Henson, J. D., Hannay, J. A., McCarthy, S. W., Royds, J. A., Yeager, T. R., Robinson, R. A., Wharton, S. B., Jellinek, D. A., Arbuckle, S. M., Yoo, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.217.11.1 · Cited by 305
Lebel, M., & Leder, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13097 · Cited by 304
Franklin, D. S., Godfrey, V. L., O'Brien, D. A., Deng, C., & Xiong, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6147-6158.2000 · Cited by 297
Current Treatment of Osteosarcoma
Ferguson, W. S., & Goorin, A. M. (2001) · Cancer Investigation · doi:10.1081/cnv-100102557 · Cited by 295
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.
Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S., Salter, D. M., Bird, C., Wyllie, A. H., & Hooper, M. L. (1994) · PubMed · Cited by 290
Membrane organization and tumorigenesis—the NF2 tumor suppressor, Merlin
McClatchey, A. I., & Giovannini, M. (2005) · Genes & Development · doi:10.1101/gad.1335605 · Cited by 286
Williams, B. O., Schmitt, E. M., Remington, L., Bronson, R. T., Albert, D. M., Weinberg, R. A., & Jacks, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06745.x · Cited by 284
Jang, J., Shin, K., & Park, J.-G. (2001) · PubMed · Cited by 273
Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
Lengner, C. J., Steinman, H. A., Gagnon, J., Smith, T. W., Henderson, J. E., Kream, B. E., Stein, G. S., Lian, J. B., & Jones, S. N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508130 · Cited by 265
Hoang, B. H., Kubo, T., Healey, J. H., Yang, R., Nathan, S. S., Kolb, E. A., Mazza, B., Meyers, P. A., & Gorlick, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1952 · Cited by 261
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Lebel, M., Spillare, E. A., Harris, C. C., & Leder, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37795 · Cited by 246
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A., & Kaelin, W. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.012 · Cited by 241
p53-Mdm2--the affair that never ends
Alarcon-Vargas, D. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.541 · Cited by 233
Ezrin, a key component in tumor metastasis
Hunter, K. W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.03.001 · Cited by 229
DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders
Mohaghegh, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.741 · Cited by 229
Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma
Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M., Sugimot, M., Kotoura, Y., & Yamamuro, T. (1989) · Nature · doi:10.1038/338156a0 · Cited by 216
Stewart, M., Terry, A., Hu, M., O’Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., & Neil, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8646 · Cited by 216
Amplification of the gli gene in childhood sarcomas.
Roberts, W. M., Douglass, E., Peiper, S., Houghton, P. J., & Look, A. T. (1989) · PubMed · Cited by 216
Characterization of MAD2B and Other Mitotic Spindle Checkpoint Genes
Cahill, D. P., da Costa, L. T., Carson-Walter, E. B., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Genomics · doi:10.1006/geno.1999.5831 · Cited by 212
Kamath-Loeb, A. S., Loeb, L. A., Johansson, E., Burgers, P. M. J., & Fry, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100253200 · Cited by 212
Defending genome integrity during DNA replication: a proposed role for RecQ family helicases
Chakraverty, R. K., & Hickson, I. D. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199904)21:4<286::aid-bies4>3.0.co;2-z · Cited by 209
Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma
Thomas, D. M., Johnson, S. A., Sims, N. A., Trivett, M. K., Slavin, J. L., Rubin, B. P., Waring, P., McArthur, G. A., Walkley, C. R., Holloway, A. J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409187 · Cited by 208
Self-citationKhanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006767007547 · Cited by 207
Enhanced Tumor Formation in Mice Heterozygous for Blm Mutation
Goss, K. H., Risinger, M. A., Kordich, J. J., Sanz, M. M., Straughen, J. E., Slovek, L. E., Capobianco, A. J., German, J., Boivin, G. P., & Groden, J. (2002) · Science · doi:10.1126/science.1074340 · Cited by 206
DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system
Suzuki, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.15.2973 · Cited by 206
FGFs, their receptors, and human limb malformations: Clinical and molecular correlations
Wilkie, A. O. M., Patey, S. J., Kan, S., van den Ouweland, A. M. W., & Hamel, B. C. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10775 · Cited by 201
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors
Chen, W. Y., Zeng, X., Carter, M. G., Morrell, C. N., Chiu Yen, R.-W., Esteller, M., Watkins, D. N., Herman, J. G., Mankowski, J. L., & Baylin, S. B. (2003) · Nature Genetics · doi:10.1038/ng1077 · Cited by 201
High metastatic potential in mice inheriting a targeted p53 missense mutation
Liu, G., McDonnell, T. J., Montes de Oca Luna, R., Kapoor, M., Mims, B., El-Naggar, A. K., & Lozano, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4174 · Cited by 199
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Feugeas, O., Guriec, N., Babin-Boilletot, A., Marcellin, L., Simon, P., Babin, S., Thyss, A., Hofman, P., Terrier, P., Kalifa, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.467 · Cited by 199
Frequency and structure of p53 rearrangements in human osteosarcoma.
Miller, C. W., Aslo, A., Tsay, C., Slamon, D. J., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. C., & Koeffler, H. P. (1990) · PubMed · Cited by 195
Overholtzer, M., Rao, P. H., Favis, R., Lu, X.-Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., & Levine, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934852100 · Cited by 193
Laud, P. R., Multani, A. S., Bailey, S. M., Wu, L., Ma, J., Kingsley, C., Lebel, M., Pathak, S., DePinho, R. A., & Chang, S. (2005) · Genes & Development · doi:10.1101/gad.1321305 · Cited by 190
c-fos expression induces bone tumors in transgenic mice.
Rüther, U., Komitowski, D. D., Schubert, F., & Wagner, E. F. (1989) · PubMed · Cited by 184
Superoxide Dismutase 1 Knock-down Induces Senescence in Human Fibroblasts
Blander, G., de Oliveira, R. M., Conboy, C. M., Haigis, M., & Guarente, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307146200 · Cited by 183
Sarcomas of bone complicating osteitis deformans (Pagetʼs disease): Fifty yearsʼ experience
Wick, M. R., McLeod, R. A., Siegal, G. P., Greditzer, H. G., & Unni, K. K. (1981) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198101000-00008 · Cited by 183
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
Scheel, C., Schaefer, K.-L., Jauch, A., Keller, M., Wai, D., Brinkschmidt, C., van Valen, F., Boecker, W., Dockhorn-Dworniczak, B., & Poremba, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204493 · Cited by 182
Physical and Functional Interaction between p53 and the Werner's Syndrome Protein
Blander, G., Kipnis, J., Leal, J. F. M., Yu, C.-E., Schellenberg, G. D., & Oren, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29463 · Cited by 181
C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression
Gamberi, G., Benassi, M. S., Bohling, T., Ragazzini, P., Molendini, L., Sollazzo, M. R., Pompetti, F., Merli, M., Magagnoli, G., Balladelli, A., et al. (1998) · Oncology · doi:10.1159/000011912 · Cited by 179
Tsuchiya, T., Sekine, K.-I., Hinohara, S.-I., Namiki, T., Nobori, T., & Kaneko, Y. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00255-1 · Cited by 179
Hoang, B. H., Kubo, T., Healey, J. H., Sowers, R., Mazza, B., Yang, R., Huvos, A. G., Meyers, P. A., & Gorlick, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11677 · Cited by 178
Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.
Tarkkanen, M., Karhu, R., Kallioniemi, A. H., et al. (1995) · PubMed · Cited by 171
Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature
Bridge, J. A., Nelson, M., McComb, E., McGuire, M. H., Rosenthal, H., Vergara, G., Maale, G. E., Spanier, S., & Neff, J. R. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00306-8 · Cited by 171
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
Chen, W., Cooper, T. K., Zahnow, C. A., Overholtzer, M., Zhao, Z., Ladanyi, M., Karp, J. E., Gokgoz, N., Wunder, J. S., Andrulis, I. L., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.030 · Cited by 165
Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.
Yamaguchi, T., Toguchida, J., Yamamuro, T., Kotoura, Y., Takada, N., Kawaguchi, N., Kaneko, Y., Nakamura, Y., Sasaki, M. S., & Ishizaki, K. (1992) · PubMed · Cited by 159
Squire, J. A., Pei, J., Marrano, P. M., Beheshti, B., Bayani, J., Lim, G., Moldovan, L., & Zieleńska, M. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10273 · Cited by 159
Roles of the Bloom's syndrome helicase in the maintenance of genome stability
Cheok, C. F., Bachrati, C. Z., Chan, K., Ralf, C., Wu, L., & Hickson, I. D. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051456 · Cited by 158
Karmakar, P., Piotrowski, J., Brosh, R. M., Sommers, J. A., Lees‐Miller, S. P., Cheng, W.-H., Snowden, C. M., Ramsden, D. A., & Bohr, V. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111523200 · Cited by 157
Cheng, S., Lecanda, F., Davidson, M. K., Warlow, P. M., Zhang, S., Zhang, L., Suzuki, S., John, T. S., & Civitelli, R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.633 · Cited by 154
Wunder, J. S., Eppert, K., Burrow, S., Gogkoz, N., Bell, R. S., & Andrulis, I. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202346 · Cited by 152
Matrix Metalloproteinases Participate in Osteosarcoma Invasion
Bjørnland, K., Flatmark, K., Pettersen, S., Aaasen, A. O., Fodstad, Ø., & Mælandsmo, G. M. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2004.12.016 · Cited by 148
Functional Interaction of p53 and BLM DNA Helicase in Apoptosis
Wang, X. W., Tseng, A., Ellis, N. A., Spillare, E. A., Linke, S. P., Robles, A. I., Seker, H., Yang, Q., Hu, P., Beresten, S. F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103298200 · Cited by 148
Retinoblastoma protein meets chromatin
Brehm, A., & Kouzarides, T. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01368-7 · Cited by 148
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8<1541::aid-cncr15>3.0.co;2-y · Cited by 147
Splicing into Senescence: The Curious Case of p16 and p19ARF
Haber, D. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80441-9 · Cited by 144
Wang, Z., Liang, J., Schellander, K., Wagner, E. F., & Grigoriadis, A. E. (1995) · PubMed · Cited by 140
Ogasawara, T., Kawaguchi, H., Jinno, S., Hoshi, K., Itaka, K., Takato, T., Nakamura, K., & Okayama, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6560-6568.2004 · Cited by 140
Paget Disease of Bone: Mapping of Two Loci at 5q35-qter and 5q31
Laurin, N., Brown, J. P., Lemainque, A., Duchesne, A., Huot, D., Lacourcière, Y., Drapeau, G., Verreault, J., Raymond, V., & Morissette, J. (2001) · The American Journal of Human Genetics · doi:10.1086/322975 · Cited by 139
Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells
Tu, Q., Valverde, P., & Chen, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.092 · Cited by 137
Forus, A., Weghuis, D. O., Smeets, D., Fodstad, Ø., Myklebost, O., & van Kessel, A. G. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140103 · Cited by 137
Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Gökgöz, N., Wunder, J. S., Mousses, S., Eskandarian, S., Bell, R. S., & Andrulis, I. L. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3 · Cited by 131
Gene amplifications in osteosarcoma—CGH microarray analysis
Atiye, J., Wolf, M., Kaur, S., Monni, O. M., Böhling, T., Kivioja, A., Tas, É., Serra, M., Tarkkanen, M., & Knuutila, S. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20120 · Cited by 130
Sharma, S., Otterlei, M., Sommers, J. A., Driscoll, H. C., Dianov, G. L., Kao, H.-I., Bambara, R. A., & Brosh, R. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0567 · Cited by 128
Bayani, J., Zieleńska, M., Pandita, A., Al-Romaih, K. I., Karásková, J., Harrison, K. J., Bridge, J. A., Sorensen, P. H. B., Thorner, P. S., & Squire, J. A. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10132 · Cited by 127
Beamish, H., Kedar, P. S., Kaneko, H., Chen, P., Fukao, T., Peng, C., Beresten, S., Gueven, N., Purdie, D. M., Lees‐Miller, S. P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203801200 · Cited by 122
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 120
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<199::aid-ijc7>3.0.co;2-4 · Cited by 120
IGF‐1 receptor contributes to the malignant phenotype in human and canine osteosarcoma
MacEwen, E. G., Pastor, J., Kutzke, J., Tsan, R. Z., Kurzman, I. D., Thamm, D. H., Wilson, M., & Radinsky, R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20046 · Cited by 118
Koken, M. H. M., Reid, A., Quignon, F., Chelbi‐Alix, M. K., Davies, J. M., Kabarowski, J. H. S., Zhu, J., Dong, S., Chen, S., Chen, Z., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10255 · Cited by 117
Growth retardation and skin abnormalities of the Recql4-deficient mouse
Hoki, Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg254 · Cited by 114
Kii, I., Amizuka, N., Shimomura, J., Saga, Y., & Kudō, A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040812 · Cited by 112
CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations
Nielsen, G. P., Burns, K. L., Rosenberg, A. E., & Louis, D. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65556-3 · Cited by 111
Nellissery, M. J., Padalecki, S. S., Brkanac, Z., Singer, F. R., Roodman, G. D., Unni, K. K., Leach, R. J., & Hansen, M. F. (1998) · The American Journal of Human Genetics · doi:10.1086/302019 · Cited by 110
Cao, Y., Zhou, Z., Crombrugghe, B. D., Nakashima, K., Guan, H., Duan, X., Jia, S.-F., & Kleinerman, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2128 · Cited by 109
Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging
Blyth, K., Terry, A., Mackay, N. A., Vaillant, F., Bell, M., Cameron, E. R., Neil, J. C., & Stewart, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204090 · Cited by 108
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 103
Felx, M., Guyot, M., Isler, M., TURCOTTE, R. E., Doyon, J., Khatib, A., Leclerc, S., Moreau, A., & Moldovan, F. (2006) · Clinical Science · doi:10.1042/cs20050286 · Cited by 101
Blyth, K., Vaillant, F., Hanlon, L., Mackay, N. A., Bell, M., Jenkins, A., Neil, J. C., & Cameron, E. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3558 · Cited by 101
Ezrin… a metastatic detERMinant?
Curto, M., & McClatchey, A. I. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00031-5 · Cited by 100
Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis
Iwaya, K., Ogawa, H., Kuroda, M., Izumi, M., Ishida, T., & Mukai, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025821229013 · Cited by 99
Alteration of pRb/p16/cdk4 regulation in human osteosarcoma
Benassi, M. S., Molendini, L., Gamberi, G., Ragazzini, P., Sollazzo, M. R., Merli, M., Asp, J., Magagnoli, G., Balladelli, A., Bertoni, F., et al. (1999) · International Journal of Cancer · Cited by 99
Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development
Barna, M., Pandolfi, P. P., & Niswander, L. A. (2005) · Nature · doi:10.1038/nature03801 · Cited by 99
Suzuki, N., Shiratori, M., Goto, M., & Furuichi, Y. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2361 · Cited by 98
Miller, C. W., Ikezoe, T., Krug, U. O., Hofmann, W., Tavor, S., Vegesna, V. R., Tsukasaki, K., Takeuchi, S., & Koeffler, H. P. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1207 · Cited by 98
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · PubMed · doi:10.1002/(sici)1097-4644(199610)63:1%3c37::aid-jcb3%3e3.0.co;2-0 · Cited by 98
Essential role of RSK2 in c-Fos–dependent osteosarcoma development
David, J., Mehic, D., Bakiri, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22877 · Cited by 95
WRN mutations in Werner syndrome
Moser, M. J., Oshima, J., & Monnat, R. J. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:4<271::aid-humu2>3.0.co;2-q · Cited by 92
Expression of transforming growth factor-? (TGF-?) isoforms in osteosarcomas
Kloen, P., Gebhardt, M. C., Pérez‐Atayde, A. R., Rosenberg, A. E., Springfield, D. S., Gold, L. I., & Mankin, H. J. (1997) · Cancer · Cited by 92
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · Journal of Cellular Biochemistry · Cited by 87
Linkage of Paget Disease of Bone to a Novel Region on Human Chromosome 18q23
Good, D. M., Busfield, F., Fletcher, B. H., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338658 · Cited by 86
Differentially amplified chromosome 12 sequences in low‐ and high‐grade osteosarcoma
Gisselsson, D., Pålsson, E., Höglund, M., Domanski, H. A., Mertens, F., Pandis, N., Sciot, R., Cin, P. D., Bridge, J. A., & Mandahl, N. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1219 · Cited by 83
Ichikawa, K., Noda, T., & Furuichi, Y. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.219 · Cited by 82
Hornebeck, W., Lambert, E., Petitfrere, E., & Bernard, P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.022 · Cited by 82
Uchibori, M., Nishida, Y., Nagasaka, T., Yamada, Y., Nakanishi, K., & Ishiguro, N. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.1.33 · Cited by 81
Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas
Entz‐Werlé, N., Stoetzel, C., Marec‐Bérard, P., Kalifa, C., Brugière, L., Pacquement, H., Schmitt, C., Tabone, M., Gentet, J., Quillet, R., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21068 · Cited by 78
Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells
Tataria, M., Quarto, N., Longaker, M. T., & Sylvester, K. G. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.12.001 · Cited by 76
Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53
Kim, H., Kwak, N., Lee, J., Choi, B. H., Lim, Y., Ko, Y. J., Kim, Y.-H., Huh, P., Lee, K.-H., Rha, H. K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305526200 · Cited by 74
Loss of p16INK4a expression correlates with decreased survival in pediatric osteosarcomas
Maitra, A., Roberts, H., Weinberg, A. G., & Geradts, J. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1<34::aid-ijc1006>3.0.co;2-v · Cited by 72
Bone morphogenetic proteins in bone tumors
Yoshikawa, H., Nakase, T., Myoui, A., & Ueda, T. (2004) · Journal of Orthopaedic Science · doi:10.1007/s00776-004-0764-9 · Cited by 71
Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma
Pakos, E. E., Kyzas, P., & Ioannidis, J. P. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0246 · Cited by 71
Amplification of 17p11.2∼p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma
van Dartel, M., Cornelissen, P. W. A., Redeker, S., Tarkkanen, M., Knuutila, S., Hogendoorn, P. C. W., Westerveld, A., Gomes, I., Bras, J., & Hulsebos, T. J. M. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00627-1 · Cited by 70
Sporadic Amplification of the MYC Gene in Human Osteosarcomas
Ladanyi, M., Park, C. K., Lewis, R., Jhanwar, S. C., Healey, J. H., & Huvos, A. G. (1993) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199309000-00004 · Cited by 69
HES1 Cooperates With pRb to Activate RUNX2-Dependent Transcription
Lee, J.-S., Thomas, D. M., Gutierrez, G. M., Carty, S. A., Yanagawa, S.-I., & Hinds, P. W. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060303 · Cited by 68
Self-citationTumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase.
Lebel, M., Cardiff, R. D., & Leder, P. (2001) · PubMed · Cited by 67
Henriksen, J. M., Ågesen, T. H., Mælandsmo, G. M., Lothe, R. A., Myklebost, O., & Forus, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206671 · Cited by 65
Atypical Osteosarcomas in Werner Syndrome (Adult Progeria)
Ishikawa, Y., Miller, R. W., Machinami, R., Sugano, H., & Goto, M. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00924.x · Cited by 60
Nimmo, R. A., Antebi, A., & Woollard, A. C. S. (2005) · Development · doi:10.1242/dev.02102 · Cited by 60
Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.
Srivastava, S., Wang, S., Tong, Y. A., Hao, Z., & Chang, E. H. (1993) · PubMed · Cited by 59
The Runx genes as dominant oncogenes
Cameron, E. R., Blyth, K., Hanlon, L., Kilbey, A., Mackay, N. A., Stewart, M. A., Terry, A., Vaillant, F., Wotton, S., & Neil, J. C. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00031-7 · Cited by 59
The Werner Syndrome: A Model for the Study of Human Aging
Nehlin, J. O., Skovgaard, G. L., & Bohr, V. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06645.x · Cited by 53
L??pez-Guerrero, J. A., L??pez-Gin??s, C., Pell??n, A., Cardá, C., & Llombart‐Bosch, A. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00004 · Cited by 52
Analysis of SAS Gene and CDK4 and MDM2 Proteins in Low-Grade Osteosarcoma
Ragazzini, Gamberi, BENASSI, V., Orlando, Sestini, R., Ferrari, C., Molendini, Sollazzo, V., Merli, Magagnoli, G., et al. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.09907.x · Cited by 52
Runx1/AML1 in leukemia: disrupted association with diverse protein partners
Perry, C., Eldor, A., & Soreq, H. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00128-x · Cited by 52
Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of the Literature
Boehm, A. K., Neff, J. R., Squire, J. A., et al. (2000) · Fetal and Pediatric Pathology · doi:10.1080/15513810009168645 · Cited by 52
Amplifications of DNA primase 1 (PRIM1) in human osteosarcoma
Yotov, W. V., Hamel, H., Rivard, G.-E., Champagne, M. A., Russo, P., Leclerc, J., Bernstein, M. L., & Levy, E. H. (1999) · Genes Chromosomes and Cancer · Cited by 52
GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade.
Stein, U., Eder, C., Karsten, U. R., Haensch, W., Walther, W., & Schlag, P. M. (1999) · PubMed · Cited by 50
Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma
Park, H., Jung, W. W., Bertoni, F., Bacchini, P., Park, J. H., Kim, Y.-W., & Park, Y.-K. (2004) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.04.006 · Cited by 48
Kawashima, A., Nakanishi, I., Okada, Y., Tsuchiya, H., Roessner, A., & Obata, K. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00191442 · Cited by 46
Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
Eischen, C. M., Rehg, J. E., Korsmeyer, S. J., & Cleveland, J. L. (2002) · PubMed · Cited by 44
Lorenzi, M. V., Horii, Y., Yamanaka, R., Sakaguchi, K., & Takashi, M. I. K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8956 · Cited by 43
Mutation analysis of the RECQL4 gene in sporadic osteosarcomas
Nishijo, K., Nakayama, T., Aoyama, T., Okamoto, T., Ishibe, T., Yasura, K., Shima, Y., Shibata, K. R., Tsuboyama, T., Nakamura, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20269 · Cited by 39
The p19INK4D Cyclin dependent kinase inhibitor gene is altered in osteosarcoma
Miller, C. W., Yeon, C., Aslo, A., Mendoza, S., Aytac, U., & Koeffler, H. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201185 · Cited by 35
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds
Siddiqui, R., Onel, K., Facio, F. M., Nafa, K., Díaz, L. R., Kauff, N. D., Huang, H. J., Robson, M. E., Ellis, N. A., & Offit, K. (2005) · Familial Cancer · doi:10.1007/s10689-004-1946-5 · Cited by 33
Metastatic osteosarcoma to lung.A clinicopathologic study of surgical biopsies and resections
Dunn, D. H., & Dehner, L. P. (1977) · Cancer · Cited by 30
Molecular Pathology and Molecular Pharmacology of Osteosarcoma
Ladanyi, M., & Gorlick, R. G. (2000) · Fetal and Pediatric Pathology · doi:10.1080/15513810009168647 · Cited by 30
Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes
Mendoza, S., David, H., Gaylord, G. M., & Miller, C. W. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.035 · Cited by 28
SAS is amplified predominantly in surface osteosarcoma
Noble-Topham, S. E., Kandel, R. A., Burrow, S. R., Bell, R. S., Eppert, K., Meltzer, P. S., & Andrulis, I. L. (1996) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100140504 · Cited by 28
Damo, L. A., Snyder, P. W., & Franklin, D. S. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20068 · Cited by 27
Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma
Johnson‐Pais, T. L., Nellissery, M. J., Ammerman, D. G., Pathmanathan, D., Bhatia, P., Buller, C. L., Leach, R. J., & Hansen, M. F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11070 · Cited by 23
Cited by
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Walkley, C. R., Qudsi, R., Sankaran, V. G., Perry, J. A., Gostissa, M., Roth, S. I., Rodda, S. J., Snay, E., Dunning, P., Fahey, F. H., et al. (2008) · Genes & Development · doi:10.1101/gad.1656808 · Cited by 373
Moore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Rb regulates fate choice and lineage commitment in vivo
Calo, E., Quintero-Estades, J. A., Danielian, P. S., Nedelcu, S., Berman, S. D., & Lees, J. A. (2010) · Nature · doi:10.1038/nature09264 · Cited by 314
Metadata
- Authors
- Kansara, M., & Thomas, D. M.
- Venue
- DNA and Cell Biology
- Publisher
- SAGE Publications
- Published
- 2007-01
- Volume
- 26
- Issue
- 1
- Pages
- 1-18
- ISSN
- 1044-5498 (ISSN-L)
- 1557-7430
- OpenAlex
- W2044332600
- Cited by
- 273
- References
- 204
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.